Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals

被引：0
|
作者：
Jagpreet Chhatwal
Tianhua He
Maria A. Lopez-Olivo
机构：
[1] Harvard Medical School,Institute for Technology Assessment, Massachusetts General Hospital
[2] Tsinghua University School of Medicine,Department of General Internal Medicine
[3] The University of Texas,undefined
[4] MD Anderson Cancer Center,undefined
来源：
PharmacoEconomics | 2016年 / 34卷
关键词：
Sustained Virological Response Rate; Telaprevir; Sofosbuvir; Boceprevir; Consolidate Health Economic Evaluation Reporting Standard;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：551 / 567
页数：16
相关论文
共 50 条
  • [11] Cost effectiveness of direct acting antivirals in the treatment of hepatitis C in vulnerable populations
    Verma, Dhruv
    Ashkar, Carina
    Saab, Sammy
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (01) : 9 - 12
  • [12] New direct-acting antivirals for the treatment of chronic hepatitis C
    Jeong, Sook-Hyang
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2015, 58 (12): : 1154 - 1158
  • [13] Benefits of Direct-Acting Antivirals for Hepatitis C
    Lok, Anna S.
    Chung, Raymond T.
    Vargas, Hugo E.
    Kim, Arthur Y.
    Naggie, Susanna
    Powderly, William G.
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (11) : 812 - +
  • [14] Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals
    Samur, Sumeyye
    Kues, Brian
    Ayer, Turgay
    Roberts, Mark S.
    Kanwal, Fasiha
    Hur, Chin
    Donnell, Drew Michael S.
    Chung, Raymond T.
    Chhatwal, Jagpreet
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (01) : 115 - +
  • [15] Future of hepatitis C therapy: development of direct-acting antivirals
    Dore, Gregory J.
    Matthews, Gail V.
    Rockstroh, Juergen
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (06) : 508 - 513
  • [16] Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil
    Holzmann, Iandra
    Tovo, Cristiane V.
    Minme, Roseline
    Leal, Monica P.
    Kliemann, Michele L.
    Ubirajara, Camila
    Aquino, Amanda A.
    Araujo, Bruna
    Almeida, Paulo R. L.
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2018, 22 (04): : 317 - 322
  • [17] Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis
    Ciaccio, Antonio
    Cortesi, Paolo A.
    Bellelli, Giuseppe
    Rota, Matteo
    Conti, Sara
    Okolicsanyi, Stefano
    Rota, Monica
    Cesana, Giancarlo
    Mantovani, Lorenzo G.
    Annoni, Giorgio
    Strazzabosco, Mario
    LIVER INTERNATIONAL, 2017, 37 (07) : 982 - 994
  • [18] Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patients
    Abad, Soraya
    Vega, Almudena
    Rincon, Diego
    Hernandez, Eduardo
    Merida, Evangelina
    Macias, Nicolas
    Munoz, Raquel
    Milla, Monica
    Luno, Jose
    Manuel Lopez-Gomez, Juan
    NEFROLOGIA, 2017, 37 (02): : 158 - 163
  • [19] Review of direct-acting antiviral agents for the treatment of chronic hepatitis C
    Shah, Nihar
    Pierce, Tracey
    Kowdley, Kris V.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (09) : 1107 - 1121
  • [20] Treatment of hepatitis C infections in the era of direct-acting antivirals (DAAs)
    Peiffer, Kai-Henrik
    Zeuzem, Stefan
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2022, 65 (02) : 246 - 253
12345